WHS2009-Oct-18  |
(0) (0 Votes)
|
Views: (802) Date: (07-05-10) Time: (00:00:17) |
Description:
Partner Lunch Symposium
Innovation Challenge - Emerging Medical Needs
Host: Novartis
Chairs: Karl Max Einhäupl | CEO | Charité – Universitätsmedizin Berlin
Jürgen Zurheide | Independent Journalist
Outline: Constant innovation in medicine has been able to provide healthcare solutions for individuals and societies on a historically
unique level. On the other hand, challenges in global healthcare are enormous. The global population is growing constantly. While
industrial countries face dramatic demographic change, some countries struggle with providing basic medical treatments. The
Novartis Symposium invites global experts to discuss these challenges and the key role of innovation in global healthcare from
different perspectives.
Welcome | Introduction
Karl Max Einhäupl | Vorstandsvorsitzender | Charité – Universitätsmedizin Berlin
Jürgen Zurheide | Independent Journalist
Challenges To Pharmaceutical And Biomedical R&D In Europe – The Economic Perspective
Panos Kanavos | Director | London School of Economics
The Demographic Challenge And How Innovation In Medicine Can Contribute.
Cornel Sieber | Head of Medical Clinic 2, Head of Institute for Biomedical Aging | FAU Erlangen-Nürnberg;
Klinikum Nürnberg Nord
Challenges In The Global Development Of Therapeutic Innovations
Trevor Mundel | Global Head of Development Pharma | Novartis Pharma AG
Summary
Karl Max Einhäupl | CEO | Charité – Universitätsmedizin Berlin